Dr. GPCR Podcast

Dr. GPCR Podcast

By Dr. Yamina BerchicheScienceLife Sciences
Download on the App Store

Dr. GPCR Podcast episodes

  • Revisit - Dr. Nicola J. Smith

    Watch the video version of this podcast episode 

    https://www.ecosystem.drgpcr.com/dr-gpcr-podcast

    ------------------------------------------- 

    Learn more about Dr. Nicola J. Smith 

    https://www.ecosystem.drgpcr.com/search?q=Nicola+Smith

    ------------------------------------------- 

    How Users can benefit Dr. GPCR Ecosystem? 

    https://www.ecosystem.drgpcr.com/explore-individuals

    ------------------------------------------- 

    How Organizations can benefit from Dr. GPCR Ecosystem? 

    https://www.ecosystem.drgpcr.com/explore-organizations

    ------------------------------------------- 

    Become a #DrGPCR Ecosystem Member 

    https://www.ecosystem.drgpcr.com/plans-pricing

    -------------------------------------------  

    Imagine a world in which the vast majority of us are healthy.  

    The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.   

    To build our #GPCR Ecosystem, we created various enabling outlets.  

    - Individuals 

    https://www.ecosystem.drgpcr.com/explore-individuals 

    - Organizations 

    https://www.ecosystem.drgpcr.com/explore-organizations

    -------------------------------------------  

    Are you a #GPCR professional?   

    -   Subscribe to #DrGPCR monthly newsletter 

    http://www.drgpcr.com/newsletter/ 

    -   Listen and subscribe to #DrGPCR Podcasts  

    http://www.drgpcr.com/podcast/ 

    -   Listen and watch GPCR focused scientific talks at #VirtualCafe 

    https://www.drgpcr.com/virtual-cafe/

    1 hr 36 min
  • Revisit - Dr. Bryan Roth

    Watch the video version of this podcast episode 

    https://www.ecosystem.drgpcr.com/dr-gpcr-podcast

    ------------------------------------------- 

    Learn more about Dr. Bryan Roth 

    https://www.ecosystem.drgpcr.com/search?q=Bryan+Roth

    ------------------------------------------- 

    How Users can benefit Dr. GPCR Ecosystem? 

    https://www.ecosystem.drgpcr.com/explore-individuals

    ------------------------------------------- 

    How Organizations can benefit from Dr. GPCR Ecosystem? 

    https://www.ecosystem.drgpcr.com/explore-organizations

    ------------------------------------------- 

    Become a #DrGPCR Ecosystem Member 

    https://www.ecosystem.drgpcr.com/plans-pricing

    -------------------------------------------  

    Imagine a world in which the vast majority of us are healthy.  

    The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.   

    To build our #GPCR Ecosystem, we created various enabling outlets.  

    - Individuals 

    https://www.ecosystem.drgpcr.com/explore-individuals 

    - Organizations 

    https://www.ecosystem.drgpcr.com/explore-organizations

    -------------------------------------------  

    Are you a #GPCR professional?   

    -   Subscribe to #DrGPCR monthly newsletter 

    http://www.drgpcr.com/newsletter/ 

    -   Listen and subscribe to #DrGPCR Podcasts  

    http://www.drgpcr.com/podcast/ 

    -   Listen and watch GPCR focused scientific talks at #VirtualCafe 

    https://www.drgpcr.com/virtual-cafe/

    1 hr 15 min
  • Revisit - Dr. Graciela Pineyro

    Watch the video version of this podcast episode 

    https://www.ecosystem.drgpcr.com/dr-gpcr-podcast

    ------------------------------------------- 

    Learn more about Dr. Graciela Pineyro 

    https://www.ecosystem.drgpcr.com/search?q=Graciela+Pineyro

    ------------------------------------------- 

    How Users can benefit Dr. GPCR Ecosystem? 

    https://www.ecosystem.drgpcr.com/explore-individuals

    ------------------------------------------- 

    How Organizations can benefit from Dr. GPCR Ecosystem? 

    https://www.ecosystem.drgpcr.com/explore-organizations

    ------------------------------------------- 

    Become a #DrGPCR Ecosystem Member 

    https://www.ecosystem.drgpcr.com/plans-pricing

    -------------------------------------------  

    Imagine a world in which the vast majority of us are healthy.  

    The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.   

    To build our #GPCR Ecosystem, we created various enabling outlets.  

    - Individuals 

    https://www.ecosystem.drgpcr.com/explore-individuals 

    - Organizations 

    https://www.ecosystem.drgpcr.com/explore-organizations

    -------------------------------------------  

    Are you a #GPCR professional?   

    -   Subscribe to #DrGPCR monthly newsletter 

    http://www.drgpcr.com/newsletter/ 

    -   Listen and subscribe to #DrGPCR Podcasts  

    http://www.drgpcr.com/podcast/ 

    -   Listen and watch GPCR focused scientific talks at #VirtualCafe 

    https://www.drgpcr.com/virtual-cafe/

    54 min
  • #80 with Dr. Andrew Tobin
    For more details, visit the #DrGPCR Podcast Episode #80 page
    https://www.drgpcr.com/episode-80-with-andrew-tobin/
    -------------------------------------------
    About Dr. Andrew Tobin

    Andrew Tobin studied Biochemistry at Queen Mary College, the University of London obtaining first-class honors before studying for a D.Phil at the University of Oxford. Following a post-doctoral period at Bristol Myers Squibb in Princeton USA, Andrew returned to the UK to establish his own laboratory at the University of Leicester. Funded through three consecutive Wellcome Trust Senior Research Fellowships Andrew established a reputation in the field of receptor signaling.


    Now at the University of Glasgow, his primary research interests are focused on the rational design of novel drugs to treat the three global health challenges of dementia, asthma, and malaria. In this Andrew runs a research laboratory of around 15 staff supported by basic research grants investigating aspects of disease biology and the action of drugs in the context of disease. The vehicle by which Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics Ltd, a biotechnology company co-founded by Andrew with series A funding from the European Union.

    Andrew is also the Director of the Advanced Research Centre (ARC) a collaborative initiative at the University of Glasgow underpinned by a £118M new build that will house over 550 researchers designed to drive interdisciplinary research.


    Dr. Andrew Tobin on the web
    • University of Glasgow 
    • ResearchGate
    • Google Scholar
    • Twitter
    • Dr. GPCR Ecosystem
    • -------------------------------------------

      Become a #DrGPCR Ecosystem Member

      -------------------------------------------

      Imagine a world in which the vast majority of us are healthy.

      The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

      To build our #GPCR Ecosystem, we created various enabling outlets.

      • Individuals
      • Organizations
      • -------------------------------------------

        Are you a #GPCR professional?

        • Subscribe to #DrGPCR Monthly Newsletter
        • Listen and subscribe to #DrGPCR Podcasts
        • Listen and watch GPCR focused scientific talks at #VirtualCafe
        • 54 min
        • #79 with Dr. Graeme Milligan
          For more details, visit the #DrGPCR Podcast Episode #79 page
          http://www.drgpcr.com/episode-79-with-graeme-milligan/
          -------------------------------------------
          About Dr. Graeme Milligan

          Professor Graeme Milligan is Gardiner Professor of Biochemistry, Dean of Research, and Deputy Head of the College of Medical, Veterinary, and Life Sciences at the University of Glasgow. His main research group centers on the function, structure, and regulation of G protein-coupled receptors (GPCRs) and their interacting proteins. His experience also includes translating knowledge generated into the selection of targets, screening, and identification of small molecule regulators of these proteins, and progressing such ligands in drug development programs.

          Prof. Milligan has published more than 550 peer-reviewed articles and his research has been cited more than 35,000 times. He was elected to the Fellowship of the Royal Society of Edinburgh in 1998 and to the Fellowship of the Academy of Medical Sciences in 2016.

          Prof. Milligan is the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for metabolic diseases including Type 2 Diabetes and other indications including non-alcoholic steatohepatitis (NASH) and inflammatory diseases and Keltic Pharma Therapeutics (2020) which is developing new treatments for malaria.

          Dr. Graeme Milligan on the web
          • University of Glasgow 
          • ResearchGate
          • PubMed
          • Orcid
          • Google Scholar
          • LinkedIn
          • -------------------------------------------

            Become a #DrGPCR Ecosystem Member

            -------------------------------------------

            Imagine a world in which the vast majority of us are healthy.

            The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

            To build our #GPCR Ecosystem, we created various enabling outlets.

            • Individuals
            • Organizations
            • -------------------------------------------

              Are you a #GPCR professional?

              • Subscribe to #DrGPCR Monthly Newsletter
              • Listen and subscribe to #DrGPCR Podcasts
              • Listen and watch GPCR focused scientific talks at #VirtualCafe
              • 56 min
              • #78 with Dr. Stuart Maudsley
                For more details, visit the #DrGPCR Podcast Episode #78 page
                https://www.drgpcr.com/episode-78-with-stuart-maudsley/ 
                -------------------------------------------
                About Dr. Stuart Maudsley

                Stuart graduated from the University of Leeds in the U.K. with a First Class Honors degree in Pharmacology. At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. He then completed his Ph.D. at Leeds as well as the University’s Ackroyd, Brotherton, and Brown Scholar.

                Following his Ph.D., Dr. Maudsley was awarded a Howard Hughes Medical Institute Fellowship to train with Professor Robert Lefkowitz at Duke University. Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology Section at the Medical Research Council (MRC) -Human Reproductive Sciences Unit within the University of Edinburgh.

                At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional signaling. To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns Hopkins University Medical Center. At the NIH he was the recipient of the coveted NIH ‘Bench-to-Bedside’ Translational Research Grant Award, one of the few awards available within the intramural NIH program. Upon starting a new family, and returning to Europe, Dr. Maudsley continued his scientific journey with the award of the highly-valued Odysseus Program Type I Program Grant to work as both the Adjunct Director of the VIB Center for Molecular Neurology and also Vice-Chair of the Department of Biomedical Sciences at the University of Antwerp.

                Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based therapeutics that interdict diseases based on their gerontological underpinnings. This research stream is now forming the basis of a new technology-based start-up company, HeptOME, to help screen and develop novel longevity/disease-regulating compounds with multidimensional disease efficacy profiles.

                -------------------------------------------

                Become a #DrGPCR Ecosystem Member

                -------------------------------------------

                Imagine a world in which the vast majority of us are healthy.

                The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

                To build our #GPCR Ecosystem, we created various enabling outlets.

                • Individuals
                • Organizations
                • -------------------------------------------

                  Are you a #GPCR professional?

                  • Subscribe to #DrGPCR Monthly Newsletter
                  • Listen and subscribe to #DrGPCR Podcasts
                  • Listen and watch GPCR focused scientific talks at #VirtualCafe
                  • 1 hr 38 min
                  • #77 with Dr. Martin Audet
                    For more details, visit the #DrGPCR Podcast Episode #77 page
                    https://www.drgpcr.com/episode-77-with-Martin-Audet/

                    -------------------------------------------

                    About Dr. Martin Audet

                    Structural biologist, pharmacologist, and a professor of pharmacology at Université de Sherbrooke. He is the head of the AudetLab located at the Institute of Pharmacology of Sherbrooke and is an emerging leader in the structural biology of G Protein-Coupled Receptors and passive transporters. Strong education with a Doctor of Philosophy (Ph.D.) in biochemistry under the supervision of Michel Bouvier at Université de Montréal, followed by a Postdoctoral Fellow at Scripps Research in San Diego and the University of Southern California in Los Angeles as a member of Raymond Stevens group.

                    Dr. Martin Audet on the web
                    • LinkedIn
                    • Twitter
                    • Sherbrooke University
                    • Google Scholar
                    • -------------------------------------------

                      Become a #DrGPCR Ecosystem Member

                      -------------------------------------------

                      Imagine a world in which the vast majority of us are healthy.

                      The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

                      To build our #GPCR Ecosystem, we created various enabling outlets.

                      • Individuals
                      • Organizations
                      • -------------------------------------------

                        Are you a #GPCR professional?

                        • Subscribe to #DrGPCR Monthly Newsletter
                        • Listen and subscribe to #DrGPCR Podcasts
                        • Listen and watch GPCR focused scientific talks at #VirtualCafe
                        • 1 hr 30 min
                        • #76 with Steve McCloskey
                          For more details, visit the #DrGPCR Podcast Episode #76 page
                          https://www.drgpcr.com/episode-76-with-Steve-McCloskey/

                          -------------------------------------------

                          About Steve McCloskey

                          Steve McCloskey is an Alumni from the first class of Nanoengineering at the University of California, San Diego. Steve’s work is focused on emerging technologies applied to Science, Technology, Engineering, and Mathematics (STEM). During his time at UC San Diego Steve worked directly with the founding Chair of the Nanoengineering Department, Ken Vecchio helping set the foundation for the Nanoengineering Materials Research Center and developing thermodynamic processing methods for Iron-based Superelastic alloys. After graduating from UCSD he founded Nanome Inc to build Virtual Reality solutions for Scientists and Engineers working at the nanoscale, specifically protein engineering and small molecule drug development.

                          Steve McCloskey on the web
                          • Website
                          • LinkedIn
                          • Twitter
                          • ResearchGate
                          • Medium
                          • Orchid
                          • -------------------------------------------

                            Become a #DrGPCR Ecosystem Member

                            -------------------------------------------

                            Imagine a world in which the vast majority of us are healthy.

                            The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

                            To build our #GPCR Ecosystem, we created various enabling outlets.

                            • Individuals
                            • Organizations
                            • -------------------------------------------

                              Are you a #GPCR professional?

                              • Subscribe to #DrGPCR Monthly Newsletter
                              • Listen and subscribe to #DrGPCR Podcasts
                              • Listen and watch GPCR focused scientific talks at #VirtualCafe
                              • 54 min
                              • Newsletter - May 2022

                                To read the full #Newsletter click here:

                                https://www.drgpcr.com/May-2022/

                                -------------------------------------------

                                Become a #DrGPCR Ecosystem Member

                                -------------------------------------------

                                Imagine a world in which the vast majority of us are healthy.

                                The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

                                To build our #GPCR Ecosystem, we created various enabling outlets.

                                • Individuals
                                • Organizations
                                • -------------------------------------------

                                  Are you a #GPCR professional? 

                                  • Subscribe to #DrGPCR Monthly Newsletter
                                  • Listen and subscribe to #DrGPCR Podcasts 
                                  • Listen and watch GPCR focused scientific talks at #VirtualCafe

                                  • 4 min
                                  • #75 with Vaithish Velazhahan
                                    For more details, visit the #DrGPCR Podcast Episode #75 page
                                    https://www.drgpcr.com/episode-75-with-vaithish-velazhahan/

                                    -------------------------------------------

                                    About Vaithish Velazhahan

                                    Vaithish obtained dual bachelor’s degrees with honors in Medical Biochemistry and Microbiology from Kansas State University, USA. His undergraduate thesis work on studying the biochemical mechanisms of flavonoids in cancer using nuclear magnetic resonance spectroscopy (NMR) led to a Barry M. Goldwater Scholarship. He then received a prestigious Gates Cambridge Scholarship to study for a Ph.D. at the MRC Laboratory of Molecular Biology and the University of Cambridge, where he is currently a final year Ph.D. candidate. His Ph.D. work has been focused on understanding the structure and activation of Class D fungal GPCRs. He has developed novel tools and methodologies to study fungal GPCRs which allowed the determination of the first structures of the prototypical fungal GPCR Ste2. This work has led to two first-authored manuscripts published in the journal Nature. Vaithish has been recognized with the MRC LMB's Max Perutz Prize for outstanding Ph.D. work and has been elected a Research Fellow at Gonville and Caius College, which is one of the most prestigious positions at the University of Cambridge.

                                    Vaithish Velazhahan on the web
                                    • Twitter
                                    • GatesCambridge
                                    • PubMed
                                    • -------------------------------------------

                                      Become a #DrGPCR Ecosystem Member

                                      -------------------------------------------

                                      Imagine a world in which the vast majority of us are healthy.

                                      The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.

                                      To build our #GPCR Ecosystem, we created various enabling outlets.

                                      • Individuals
                                      • Organizations
                                      • -------------------------------------------

                                        Are you a #GPCR professional? 

                                        • Subscribe to #DrGPCR Monthly Newsletter
                                        • Listen and subscribe to #DrGPCR Podcasts 
                                        • Listen and watch GPCR focused scientific talks at #VirtualCafe

                                        • 53 min

                                        About Dr. GPCR Podcast

                                        From the publisher's feed

                                        We bring you closer to dedicated scientists who work tirelessly to help understand GPCR pathophysiology.

                                        More shows like Dr. GPCR Podcast

                                        Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

                                        Biotech Hangout

                                        20 Listeners